Marine Drugs (Feb 2012)

Two New Tryptamine Derivatives, Leptoclinidamide and (-)-Leptoclinidamine B, from an Indonesian Ascidian Leptoclinides dubius

  • Michio Namikoshi,
  • Remy E. P. Mangindaan,
  • Hiroyuki Yamazaki,
  • Defny S. Wewengkang,
  • Henki Rotinsulu,
  • Teruaki Nishikawa

DOI
https://doi.org/10.3390/md10020349
Journal volume & issue
Vol. 10, no. 2
pp. 349 – 357

Abstract

Read online

Two new tryptamine-derived alkaloids, named as leptoclinidamide (1) and (-)-leptoclinidamine B (2), were isolated from an Indonesian ascidian Leptoclinides dubius together with C2-α-D-mannosylpyranosyl-L-tryptophan (3). The structure of 1 was assigned on the basis of spectroscopic data for 1 and its N-acetyl derivative (4). Compound 1 was an amide of tryptamine with two β-alanine units. Although the planar structure of 2 is identical to that of the known compound (+)-leptoclinidamine B (5), compound 2 was determined to be the enantiomer of 5 based on amino acid analysis using HPLC methods. Compounds 1 to 4 were evaluated for cytotoxicity against two human cancer cell lines, HCT-15 (colon) and Jurkat (T-cell lymphoma) cells, but none of the compounds showed activity.

Keywords